Indexischemic 57, 79, 80, 216, 247–9
mortality rate 198
prevention 247–8, 254
Stroke Prevention with the Oral Direct Thrombin
Inhibitor Ximelagatran 254
“Subclavian steal syndrome” 345
Suction, cardiotomy 138
Sudden cardiac death 270–92
Sudden Cardiac Death in Heart Failure Trial. See
SCD-HeFT
Sudden unexplained nocturnal death syndrome. See SUNDS
Sulfonamides 241
SUNDS 237, 239–40
Supplements, antioxidant vitamin 216, 220
Support
inotropic 69, 71
vasopressor 69, 70
Supraventricular arrhythmias 255–69
Supraventricular tachycardia. See SVT
Surgery
bypass 144
coronary 146
mitral valve prolapse 293
noncardiac 154–5, 163
nonvascular 155
urgent/emergent 163
valve 142, 144
vascular 152, 155, 158, 160–1, 163
Survival 135–6, 139, 142–3, 145–8, 278, 281–9
SVT 256, 258–9, 268–9
Syncope 239–40, 255, 270, 272, 274–5, 278, 282, 284–8, 294
SYNERGY 29
Systematic Coronary Risk Evaluation 195, 221
Systolic blood pressure. See SBP
T-wave alternans. See TWA
Tachyarrhythmia 275, 287
supraventricular 286
ventricular 71
Tachycardia 17, 34, 54, 64–5, 67, 75, 160, 164, 240, 255–7,
259–64, 268–9, 273, 284, 289, 291
atrial fl utter 266
atrioventricular reciprocating 256–8, 260–2, 264
focal atrial 256, 263–6
focal junctional 262
mechanism 266
nonparoxysmal junction 262
pathway-mediated 255
QRS 256–61, 275–6, 284, 286
sinus 55, 259–60
ventricular 150, 271–2, 276, 285
recurrent 281
Tadalafi l 33
Tafazzin 241
Tako-tsubo 236–7, 242
Tamponade, pericardial 69
TASC 166, 185
TBI 165, 168, 170, 176, 182–3
TEE 182–3, 252, 267, 313–4, 316
Telmisartan 227
Tenecteplase 57
Testing
Allen’s 167
liver function 225
noninvasive stress 38
pharmacological stress 39. See also Exercise
Therapy 226, 230, 232–5
5-fl uorouracil 291
ablative 266
adjunctive 181, 275, 285
antiplatelet and antithrombotic 117, 130–2
aldosterone blocking 109
alternative 225–6
amiodarone 284
analgesic 32
ancillary 62, 127
anti-anginal 23
antiarrhythmic 72–3, 250–4, 286–8
antibiotic 309–10, 313–5, 318, 321–3, 331–2
anticoagulation 34, 37–8, 45, 57, 62–3, 68, 127, 175,
246–8, 252
antihypertensive 173, 196–7, 200–1, 206–8
anti-ischemic 32
antiplatelet 28, 34–7, 41, 45, 57, 84, 141, 167–8, 174–6,
185–6, 335
antithrombotic 28, 35–7, 86, 246–8
arrhythmic 271. See also Arrhythmia
behavior modifi cation 175
beta-blocker 17, 25–6, 33–4, 42–3, 46, 55, 64, 66–7, 70,
78, 87, 114, 116, 139–40, 152, 155–6, 160–1, 163–4,
206–10, 213, 217, 220, 227, 229–30, 232–5, 245–6,
251, 259, 261–5, 267, 276–8, 281, 286–8, 291
cardiac resynchronization 230, 292
ceftriaxone 318
cholesterol-lowering 187–91
clopidogrel. See Clopidogrel
conservative 38
“destination” 231
diabetic 175
dietary 191. See also Diet
digoxin 268
double beta-lactam 335
drug 190–2, 194, 258, 260, 262, 266–8, 275, 285, 288
endovascular 177
evidence-based 232
fi brate 219